Growth Hormone Deficiency News and Research

RSS

Human growth hormone abuse raises serious health risks

Human growth hormone (HGH), when medically necessary, is a safe and effective clinical treatment for children and adults.

13 Feb 2008

RNA interference therapy heals growth deficiency disorder in a live animal

A team of Vanderbilt researchers have demonstrated for the first time that a new type of gene therapy, called RNA interference, can heal a genetic disorder in a live animal.

20 Dec 2007

Height linked to how good a person thinks their health is

Your height in adult life significantly affects your quality of life, with short people reporting worse physical and mental health than people of normal height.

18 Oct 2007

St. Jude follows outcomes of stem cell transplant survivors

Patient care at St. Jude doesn't stop when the child is cured. The end of successful therapy is the start of many years of follow-up care. This care is aimed at helping make the recovery process successful and preparing the family and hometown doctor for long-term complications that might arise from the disease or its treatment.

11 Sep 2007

Researchers develop a long-acting growth hormone for use in human therapy

The new discovery could mean that children and adults with growth hormone disorders will not have to have injections as often, reducing the need for daily treatments.

5 Sep 2007

Review of the routine monitoring of growth in children of primary school age to identify growth-related conditions

No sound evidence supports weight monitoring to identify and treat obese children, according to a review of worldwide research published this month in the United Kingdom.

23 Jun 2007

FDA approves Norditropin for short stature in children with Noonan syndrome

Novo Nordisk has announced that Norditropin (somatropin[rDNA origin] injection) received U.S. Food and Drug Administration (FDA) approval for the treatment of short stature in children with Noonan syndrome.

3 Jun 2007

Bariatric surgery - possible treatment for type 2 diabetes mellitus

What role could bariatric surgery possibly play as a treatment for type 2 diabetes mellitus? This topic and several others will be discussed at the American Association of Clinical Endocrinologists (AACE) Sixteenth Annual Meeting & Clinical Congress, Thursday, April 12, 2007 at the Washington State Convention & Trade Center in Seattle.

5 Apr 2007

Merck Serono launches growth hormone injection device

Merck Serono has announced the launch of a unique growth hormone injection device, easypod, for the once-daily administration of Saizen (somatropin), the company's recombinant growth hormone deficiency therapy. easypod is the first of its kind in this therapeutic area and was designed to improve patients' ease of daily use, reliability and convenience.

30 Jan 2007

Experimental drug helps you age gracefully

Researchers in the U.S. say they believe an experimental drug designed to kick-start growth hormones in humans may also be of advantage in the aging process.

22 Jun 2006

IGF-based growth hormone dosing could become a novel paradigm in treating growth hormone deficiency

A randomized University of California - Los Angeles (UCLA) study found that a new dosing paradigm can improve height outcomes in the treatment of children who have short stature due to growth hormone deficiency and idiopathic short stature.

6 Jun 2005

Serono announces the availability of Saizen for adult growth hormone deficiency

Serono announced today the availability of Saizen [somatropin (rDNA origin) for injection] for use in the treatment of patients with adult growth hormone deficiency (AGHD), following its FDA approval.

10 Jan 2005

New guidelines today to diagnose and treat acromegaly

The American Association of Clinical Endocrinologists (AACE) released new guidelines today to diagnose and treat acromegaly, a rare and debilitating endocrine disorder. The guidelines are published in the May/June 2004 issue of AACE's peer-reviewed journal Endocrine Practice.

29 Aug 2004

Latest research on obesity, diabetes, hormone replacement therapy to be presented

From reviewing the latest trends and clinical research in the field of endocrinology to debating the nation's obesity epidemic and the ethnic disparities in health care, the American Association of Clinical Endocrinologists' (AACE) Thirteenth Annual Meeting and Clinical Congress will highlight the current revolution in endocrinology.

29 Apr 2004

Results of Creutzfeldt-Jakob disease research in people who received human growth hormone from cadavers

The largest study of its kind, designed to track the development of Creutzfeldt-Jakob disease in people who received human growth hormone from cadavers, has found that the vast majority of those who received the hormone did not contract the fatal condition. However, some recipients (26 out of approximately 7,700) did develop the disease.

7 Apr 2004